YiChang HEC ChangJiang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
YiChang HEC ChangJiang Pharmaceutical has a total shareholder equity of CN¥8.7B and total debt of CN¥2.1B, which brings its debt-to-equity ratio to 23.9%. Its total assets and total liabilities are CN¥12.5B and CN¥3.8B respectively. YiChang HEC ChangJiang Pharmaceutical's EBIT is CN¥2.1B making its interest coverage ratio 30.4. It has cash and short-term investments of CN¥1.5B.
Key information
23.9%
Debt to equity ratio
CN¥2.07b
Debt
| Interest coverage ratio | 30.4x |
| Cash | CN¥1.52b |
| Equity | CN¥8.67b |
| Total liabilities | CN¥3.83b |
| Total assets | CN¥12.49b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1558's short term assets (CN¥5.5B) exceed its short term liabilities (CN¥2.5B).
Long Term Liabilities: 1558's short term assets (CN¥5.5B) exceed its long term liabilities (CN¥1.3B).
Debt to Equity History and Analysis
Debt Level: 1558's net debt to equity ratio (6.3%) is considered satisfactory.
Reducing Debt: 1558's debt to equity ratio has reduced from 74.6% to 23.9% over the past 5 years.
Debt Coverage: 1558's debt is well covered by operating cash flow (21.9%).
Interest Coverage: 1558's interest payments on its debt are well covered by EBIT (30.4x coverage).